Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “ASTRO”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 271 records · Page 15
All sourcesNASA NTRSDOE OSTI
NASA NTRS2016

Final Summary of On-Orbit ADR Operation on Hitomis Soft X-Ray Spectrometer Instrument

The Soft X-ray Spectrometer (SXS) on the Astro-H observatory contains a 6x6 array of x-ray microcalorimeters that are cooled to 50 mK by an adiabatic demagnetization refrigerator (ADR). The ADR consists of three stages in order to provide stable detector cooling using either a 1.2 K superfluid helium bath or a 4.5 K Joule-Thomson (JT) cryocooler as its heat sink. Astro-H was renamed Hitomi after it was successfully launched in February 2016. The SXS carried approximately 36 liters of helium into orbit, and by day 5 the helium had cooled sufficiently (1.4 K) to allow operation of the ADR. This paper summarizes the ADRs performance during the 38 days that the satellite was operational.

space astronomy↗
NASA NTRS2010

Multi-Stage ADRs for Current and Future Astronomy Missions: Performance and Requirements for Cryogen-Free Operation

The cooling requirements for current (e.g. Astro-H) and future (e.g. IXO and ASP) astronomy missions pose significant challenges for the sub-Kelvin Cooler. In particular, the use of large detector arrays increases the cooling power needed, and the variety of cryocoolers that can be used for pre-cooling greatly expands the range of temperatures at which the sub-Kelvin cooler can be designed to reject heat. In most cases, there is also a need for a stable higher temperature stage for cooling amplifiers or telescope components. NASA/GSFC is currently building a 3-stage ADR for the Astro-H mission, and is developing a 5-stage ADR suitable for IXO and ASP, as well as many other missions in the early planning stages. The architecture of these ADRs allows them to be adapted rather easily for different cooling requirements and to accommodate different cryocooler capabilities (operating temperature and cooling power). This paper will discuss the performance of these ADRs, which operate in both continuous, and single-shot cooling modes, and the minimum cryocooler capabilities needed to meet the requirements of future missions.

Shirron, Peter↗
NASA NTRS2018

Design and On-Orbit Operation of the Adiabatic Demagnetization Refrigerator on the Hitomi Soft X-Ray Spectrometer Instrument

The Soft X-ray Spectrometer instrument on the Astro-H observatory contains a 6x6 array of x-ray microcalorimeters that is cooled to 50 mK by an adiabatic demagnetization refrigerator (ADR). The ADR consists of three stages in order to provide stable detector cooling using either a 1.2 K superfluid helium bath or a 4.5 K Joule-Thomson (JT) cryocooler as its heat sink. When liquid helium is present, two of the ADR's stages are used to single-shot cool the detectors while rejecting heat to the helium. After the helium is depleted, all three stages are used to continuously cool the helium tank (to about 1.5 K) and single-shot cool the detectors (to 50 mK), using the JT cryocooler as its heat sink. The Astro-H observatory, renamed Hitomi after its successful launch in February 2016, carried approximately 36 liters of helium into orbit. On day 5, the helium had cooled sufficiently (<1.4 K) to allow operation of the ADR. This paper describes the design, operation and on-orbit performance of the ADR, and the use of the ADR's heat rejection as a tool for mass gauging the helium tank.

adiabatic demagnetization refrigerator↗
NASA NTRS2017

Porous Plug Phase Separator and Superfluid Film Flow Suppression System for the Soft X-Ray Spectrometer Onboard Hitomi

When using superfluid helium in low gravity environments, porous plug phase separators are commonly used to vent boiloff gas while confining the bulk liquid to the tank. Invariably, there is a flow of superfluid film from the perimeter of the porous plug down the vent line. For the Soft X-ray Spectrometer onboard ASTRO-H (Hitomi), its approximately 30-liter helium supply has a lifetime requirement of more than 3 years. A nominal vent rate is estimated as ~ 30 ug/s, equivalent to ~ 0.7 mW heat load. It is therefore critical to suppress any film flow whose evaporation would not provide direct cooling of the remaining liquid helium. That is, the porous plug vent system must be designed to both minimize film flow and to ensure maximum extraction of latent heat from the film. The design goal for Hitomi is to reduce the film flow losses to <2 ug/s, corresponding to a loss of cooling capacity of <40 uW. The design adopts the same general design as implemented for Astro-E and E2, using a vent system composed of a porous plug, combined with an orifice, a heat exchanger, and knife-edge devices. In this paper, design, on-ground testing results and in-orbit performance are described.

Porous↗
DOE OSTI2015

Gas density fluctuations in the Perseus Cluster: clumping factor and velocity power spectrum

X-ray surface brightness fluctuations in the core of the Perseus Cluster are analysed, using deep observations with the Chandra observatory. The amplitude of gas density fluctuations on different scales is measured in a set of radial annuli. It varies from 7 to 12 per cent on scales of ~10–30 kpc within radii of 30–220 kpc from the cluster centre. Using a statistical linear relation between the observed amplitude of density fluctuations and predicted velocity, the characteristic velocity of gas motions on each scale is calculated. The typical amplitudes of the velocity outside the central 30 kpc region are 90–140 km s -1 on ~20–30 kpc scales and 70–100 km s -1 on smaller scales ~7–10 kpc. The velocity power spectrum (PS) is consistent with cascade of turbulence and its slope is in a broad agreement with the slope for canonical Kolmogorov turbulence. The gas clumping factor estimated from the PS of the density fluctuations is lower than 7–8 per cent for radii ~30–220 kpc from the centre, leading to a density bias of less than 3–4 per cent in the cluster core. Uncertainties of the analysis are examined and discussed. Future measurements of the gas velocities with the Astro-H, Athena and Smart-X observatories will directly measure the gas density–velocity perturbation relation and further reduce systematic uncertainties in this analysis.

79 ASTRONOMY AND ASTROPHYSICS↗
DOE OSTI2011

Section on Supernova Remnants and Cosmic Rays of the White Paper on the Status and Future of Ground-Based Gamma-Ray Astronomy

This is a report on the findings of the SNR/cosmic-ray working group for the white paper on the status and future of ground-based gamma-ray astronomy. The white paper is an APS commissioned document, and the overall version has also been released and can be found on astro-ph. This detailed section of the white paper discusses the status of past and current attempts to observe shell-type supernova remnants and diffuse emission from cosmic rays at GeV-TeV energies. We concentrate on the potential of future ground-based gamma-ray experiments to study the acceleration of relativistic charged particles which is one of the main unsolved, yet fundamental, problems in modern astrophysics. The acceleration of particles relies on interactions between energetic particles and magnetic turbulence. In the case of SNRs we can perform spatially resolved studies in systems with known geometry, and the plasma physics deduced from these observations will help us to understand other systems where rapid particle acceleration is believed to occur and where observations as detailed as those of SNRs are not possible.

71 CLASSICAL AND QUANTUM MECHANICS, GENERAL PHYSIC↗
NASA NTRS2017

In-orbit Operation of the Soft X-Ray Spectrometer Onboard the Hitomi Satellite

We summarize all of the in-orbit operations of the soft x-ray spectrometer (SXS) onboard the ASTRO-H (Hitomi) satellite. The satellite was launched on February 17, 2016, and the communication with the satellite ceased on March 26, 2016. The SXS was still in the commissioning phase, in which the set-ups were progressively changed. This paper is intended to serve as a concise reference of the events in orbit in order to properly interpret the SXS data taken during its short lifetime and as a test case for planning the in-orbit operation for future microcalorimeter missions.

ASTRO-H↗
DOE OSTI2014

Light neutralino dark matter: direct/indirect detection and collider searches

We study the neutralino being the Lightest Supersymmetric Particle (LSP) as a cold Dark Matter (DM) candidate with a mass less than 40 GeV in the framework of the Next-to-Minimal-Supersymmetric-Standard-Model (NMSSM). We find that with the current collider constraints from LEP, the Tevatron and the LHC, there are three types of light DM solutions consistent with the direct/indirect searches as well as the relic abundance considerations: (i) A 1 , H 1 -funnels, (ii) stau coannihilation and (iii) sbottom coannihilation. Type-(i) may take place in any theory with a light scalar (or pseudo-scalar) near the LSP pair threshold; while Type-(ii) and (iii) could occur in the framework of Minimal-Supersymmetric-Standard-Model (MSSM) as well. We present a comprehensive study on the properties of these solutions and point out their immediate relevance to the experiments of the underground direct detection such as superCDMS and LUX/LZ, and the astro-physical indirect search such as Fermi-LAT. We also find that the decays of the SM-like Higgs boson may be modified appreciably and the new decay channels to the light SUSY particles may be sizable. The new light CP-even and CP-odd Higgs bosons will decay to a pair of LSPs as well as other observable final states, leading to interesting new Higgs phenomenology at colliders. For the light sfermion searches, the signals would be very challenging to observe at the LHC given the current bounds. Furthermore, a high energy and high luminosity lepton collider, such as the ILC, would be able to fully cover these scenarios by searching for events with large missing energy plus charged tracks or displaced vertices.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗
DOE OSTI2012

A Research Agenda for Radiation Oncology: Results of the Radiation Oncology Institute's Comprehensive Research Needs Assessment

Purpose: To promote the rational use of scarce research funding, scholars have developed methods for the systematic identification and prioritization of health research needs. The Radiation Oncology Institute commissioned an independent, comprehensive assessment of research needs for the advancement of radiation oncology care. Methods and Materials: The research needs assessment used a mixed-method, qualitative and quantitative social scientific approach, including structured interviews with diverse stakeholders, focus groups, surveys of American Society for Radiation Oncology (ASTRO) members, and a prioritization exercise using a modified Delphi technique. Results: Six co-equal priorities were identified: (1) Identify and develop communication strategies to help patients and others better understand radiation therapy; (2) Establish a set of quality indicators for major radiation oncology procedures and evaluate their use in radiation oncology delivery; (3) Identify best practices for the management of radiation toxicity and issues in cancer survivorship; (4) Conduct comparative effectiveness studies related to radiation therapy that consider clinical benefit, toxicity (including quality of life), and other outcomes; (5) Assess the value of radiation therapy; and (6) Develop a radiation oncology registry. Conclusions: To our knowledge, this prioritization exercise is the only comprehensive and methodologically rigorous assessment of research needs in the field of radiation oncology. Broad dissemination of these findings is critical to maximally leverage the impact of this work, particularly because grant funding decisions are often made by committees on which highly specialized disciplines such as radiation oncology are not well represented.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2013

Feasibility of MR Imaging/MR Spectroscopy-Planned Focal Partial Salvage Permanent Prostate Implant (PPI) for Localized Recurrence After Initial PPI for Prostate Cancer

Purpose: To assess the feasibility of magnetic resonance imaging (MRI)-planned partial salvage permanent prostate implant (psPPI) among patients with biopsy-proven local recurrence after initial PPI without evidence of distant disease. Methods and Materials: From 2003-2009, 15 patients underwent MRI/magnetic resonance spectroscopy (MRS) planning for salvage brachytherapy (psPPI, I-125 [n=14; 144 Gy]; Pd-103 [n=1; 125 Gy]) without hormone therapy. Full dose was prescribed to areas of recurrence and underdosage, without entire prostate implantation. Limiting urethral and rectal toxicity was prioritized. Follow-up was from salvage date to prostate-specific antigen (PSA) concentration failure (Phoenix criteria = nadir + 2.0; ASTRO = 3 consecutive rises), recurrence, distant metastases, or last follow-up PSA level. Progression-free survival (PFS) was defined as no PSA failure or biopsy-proven recurrence without all-cause mortality. Toxicity was scored using Common Terminology Criteria for Adverse Events version 4.0. Results: At salvage, median age was 68 years, and PSA concentration was 3.5 ng/mL (range, 0.9-5.6 ng/mL). Abnormal MRI/MRS findings were evident in 40% of patients. Biopsy-proven recurrences consisted of a single focus (80%) or 2 foci (20%). At recurrence, Gleason score was 6 (67%) or {>=}7 (27%). Median interval between initial and salvage implantation was 69 months (range, 28-132 months). psPPI planning characteristics limited doses to the rectum (mean V100 = 0.5% [0.07 cc]) and urethra (V100 = 12% [0.3 cc]). At median follow-up (23.3 months; range, 8-88 months), treatment failure (n=2) resulted only in localized recurrence; both patients underwent second psPPI with follow-up PSA tests at 12 and 26 months, resulting in 0.6 and 0.7 ng/mL, respectively. American Society for Radiation Oncology PFS rates at 1, 2, and 3 years were 86.7%, 78.4%, and 62.7%, respectively, with 5 patients for whom treatment failed (n=3 with negative transrectal ultrasound-guided biopsy results). Phoenix PFS rates at 1, 2, and 3 years were 100%, 100%, and 71.4%. 73%, respectively; achieved PSA nadir of <0.5 ng/mL; and 47% of patients had a nadir of <0.1 ng/mL. Treatment-related toxicity was minimal, with no operative interventions, fistulas, or other grade {>=}3 gastrointestinal (GI)/genitourinary (GU) toxicity. Thirteen percent had grade 1 GI and 33% had grade 2 GU toxicities. Postsalvage, 20% of patients had no erectile dysfunction, 67% of patients had medication-responsive erectile dysfunction, and 13% of patients had erectile dysfunction refractory to medication. Conclusions: Focal psPPI with MR-planning in highly selected patients is feasible with short-term control comparable to conventional salvage, with less toxicity. Longer follow-up is needed to confirm its impact on quality of life and treatment.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2013

An Assessment of the Current US Radiation Oncology Workforce: Methodology and Global Results of the American Society for Radiation Oncology 2012 Workforce Study

Purpose: To determine the characteristics, needs, and concerns of the current radiation oncology workforce, evaluate best practices and opportunities for improving quality and safety, and assess what we can predict about the future workforce. Methods and Materials: An online survey was distributed to 35,204 respondents from all segments of the radiation oncology workforce, including radiation oncologists, residents, medical dosimetrists, radiation therapists, medical physicists, nurse practitioners, nurses, physician assistants, and practice managers/administrators. The survey was disseminated by the American Society for Radiation Oncology (ASTRO) together with specialty societies representing other workforce segments. An overview of the methods and global results is presented in this paper. Results: A total of 6765 completed surveys were received, a response rate of 19%, and the final analysis included 5257 respondents. Three-quarters of the radiation oncologists, residents, and physicists who responded were male, in contrast to the other segments in which two-thirds or more were female. The majority of respondents (58%) indicated they were hospital-based, whereas 40% practiced in a free-standing/satellite clinic and 2% in another setting. Among the practices represented in the survey, 21.5% were academic, 25.2% were hospital, and 53.3% were private. A perceived oversupply of professionals relative to demand was reported by the physicist, dosimetrist, and radiation therapist segments. An undersupply was perceived by physician's assistants, nurse practitioners, and nurses. The supply of radiation oncologists and residents was considered balanced. Conclusions: This survey was unique as it attempted to comprehensively assess the radiation oncology workforce by directly surveying each segment. The results suggest there is potential to improve the diversity of the workforce and optimize the supply of the workforce segments. The survey also provides a benchmark for future studies, as many changes in the healthcare field exert pressure on the workforce.

29 ENERGY PLANNING, POLICY, AND ECONOMY↗
DOE OSTI2014

Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or to discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2015

Technology for Innovation in Radiation Oncology

Radiation therapy is an effective, personalized cancer treatment that has benefited from technological advances associated with the growing ability to identify and target tumors with accuracy and precision. Given that these advances have played a central role in the success of radiation therapy as a major component of comprehensive cancer care, the American Society for Radiation Oncology (ASTRO), the American Association of Physicists in Medicine (AAPM), and the National Cancer Institute (NCI) sponsored a workshop entitled “Technology for Innovation in Radiation Oncology,” which took place at the National Institutes of Health (NIH) in Bethesda, Maryland, on June 13 and 14, 2013. The purpose of this workshop was to discuss emerging technology for the field and to recognize areas for greater research investment. Expert clinicians and scientists discussed innovative technology in radiation oncology, in particular as to how these technologies are being developed and translated to clinical practice in the face of current and future challenges and opportunities. Technologies encompassed topics in functional imaging, treatment devices, nanotechnology, and information technology. The technical, quality, and safety performance of these technologies were also considered. A major theme of the workshop was the growing importance of innovation in the domain of process automation and oncology informatics. The technologically advanced nature of radiation therapy treatments predisposes radiation oncology research teams to take on informatics research initiatives. In addition, the discussion on technology development was balanced with a parallel conversation regarding the need for evidence of efficacy and effectiveness. The linkage between the need for evidence and the efforts in informatics research was clearly identified as synergistic.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2016

Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members

Purpose: To survey image guided radiation therapy (IGRT) practice patterns, as well as IGRT's impact on clinical workflow and planning treatment volumes (PTVs). Methods and Materials: A sample of 5979 treatment site–specific surveys was e-mailed to the membership of the American Society for Radiation Oncology (ASTRO), with questions pertaining to IGRT modality/frequency, PTV expansions, method of image verification, and perceived utility/value of IGRT. On-line image verification was defined as images obtained and reviewed by the physician before treatment. Off-line image verification was defined as images obtained before treatment and then reviewed by the physician before the next treatment. Results: Of 601 evaluable responses, 95% reported IGRT capabilities other than portal imaging. The majority (92%) used volumetric imaging (cone-beam CT [CBCT] or megavoltage CT), with volumetric imaging being the most commonly used modality for all sites except breast. The majority of respondents obtained daily CBCTs for head and neck intensity modulated radiation therapy (IMRT), lung 3-dimensional conformal radiation therapy or IMRT, anus or pelvis IMRT, prostate IMRT, and prostatic fossa IMRT. For all sites, on-line image verification was most frequently performed during the first few fractions only. No association was seen between IGRT frequency or CBCT utilization and clinical treatment volume to PTV expansions. Of the 208 academic radiation oncologists who reported working with residents, only 41% reported trainee involvement in IGRT verification processes. Conclusion: Consensus guidelines, further evidence-based approaches for PTV margin selection, and greater resident involvement are needed for standardized use of IGRT practices.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2016

Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025

Purpose: Prior studies have forecasted demand for radiation therapy to grow 10 times faster than the supply between 2010 and 2020. We updated these projections for 2015 to 2025 to determine whether this imbalance persists and to assess the accuracy of prior projections. Methods and Materials: The demand for radiation therapy between 2015 and 2025 was estimated by combining current radiation utilization rates determined by the Surveillance, Epidemiology, and End Results data with population projections provided by the US Census Bureau. The supply of radiation oncologists was forecast by using workforce demographics and full-time equivalent (FTE) status provided by the American Society for Radiation Oncology (ASTRO), current resident class sizes, and expected survival per life tables from the US Centers for Disease Control. Results: Between 2015 and 2025, the annual total number of patients receiving radiation therapy during their initial treatment course is expected to increase by 19%, from 490,000 to 580,000. Assuming a graduating resident class size of 200, the number of FTE physicians is expected to increase by 27%, from 3903 to 4965. In comparison with prior projections, the new projected demand for radiation therapy in 2020 dropped by 24,000 cases (a 4% relative decline). This decrease is attributable to an overall reduction in the use of radiation to treat cancer, from 28% of all newly diagnosed cancers in the prior projections down to 26% for the new projections. By contrast, the new projected supply of radiation oncologists in 2020 increased by 275 FTEs in comparison with the prior projection for 2020 (a 7% relative increase), attributable to rising residency class sizes. Conclusion: The supply of radiation oncologists is expected to grow more quickly than the demand for radiation therapy from 2015 to 2025. Further research is needed to determine whether this is an appropriate correction or will result in excess capacity.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2014

The radiation oncology workforce: A focus on medical dosimetry

The 2012 Radiation Oncology Workforce survey was conducted to assess the current state of the entire workforce, predict its future needs and concerns, and evaluate quality improvement and safety within the field. This article describes the dosimetrist segment results. The American Society for Radiation Oncology (ASTRO) Workforce Subcommittee, in conjunction with other specialty societies, conducted an online survey targeting all segments of the radiation oncology treatment team. The data from the dosimetrist respondents are presented in this article. Of the 2573 dosimetrists who were surveyed, 890 responded, which resulted in a 35% segment response rate. Most respondents were women (67%), whereas only a third were men (33%). More than half of the medical dosimetrists were older than 45 years (69.2%), whereas the 45 to 54 years age group represented the highest percentage of respondents (37%). Most medical dosimetrists stated that their workload was appropriate (52%), with respondents working a reported average of 41.7 ± 4 hours per week. Overall, 86% of medical dosimetrists indicated that they were satisfied with their career, and 69% were satisfied in their current position. Overall, 61% of respondents felt that there was an oversupply of medical dosimetrists in the field, 14% reported that supply and demand was balanced, and the remaining 25% felt that there was an undersupply. The medical dosimetrists' greatest concerns included documentation/paperwork (78%), uninsured patients (80%), and insufficient reimbursement rates (87%). This survey provided an insight into the dosimetrist perspective of the radiation oncology workforce. Though an overwhelming majority has conveyed satisfaction concerning their career, the study allowed a spotlight to be placed on the profession's current concerns, such as insufficient reimbursement rates and possible oversupply of dosimetrists within the field.

61 RADIATION PROTECTION AND DOSIMETRY↗